WO2004060433A3 - Delivery devices - Google Patents

Delivery devices Download PDF

Info

Publication number
WO2004060433A3
WO2004060433A3 PCT/IB2004/000294 IB2004000294W WO2004060433A3 WO 2004060433 A3 WO2004060433 A3 WO 2004060433A3 IB 2004000294 W IB2004000294 W IB 2004000294W WO 2004060433 A3 WO2004060433 A3 WO 2004060433A3
Authority
WO
WIPO (PCT)
Prior art keywords
substance
nasal
delivering
subject
delivery device
Prior art date
Application number
PCT/IB2004/000294
Other languages
French (fr)
Other versions
WO2004060433A2 (en
Inventor
Per Gisle Djupesland
Original Assignee
Optinose As
Per Gisle Djupesland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Optinose As, Per Gisle Djupesland filed Critical Optinose As
Publication of WO2004060433A2 publication Critical patent/WO2004060433A2/en
Publication of WO2004060433A3 publication Critical patent/WO2004060433A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • A61M15/0098Activated by exhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Abstract

A delivery device for and method of delivering substance to a subject, in particular a nasal delivery device for delivering a substance to a subject through nasal mucosa in a nasal cavity of the subject, the delivery device comprising: a nozzle (25) for delivering a particulate aerosol containing a substance to nasal mucosa in the nasal cavity; and a substance supply unit (29) actuatable to supply substance to the nozzle(25); wherein at least a fraction of the particles of the aerosol has a dimension and velocity such as to penetrate through the nasal mucosa.
PCT/IB2004/000294 2003-01-02 2004-01-02 Delivery devices WO2004060433A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0300008.0A GB0300008D0 (en) 2003-01-02 2003-01-02 Delivery devices
GB0300008.0 2003-01-02

Publications (2)

Publication Number Publication Date
WO2004060433A2 WO2004060433A2 (en) 2004-07-22
WO2004060433A3 true WO2004060433A3 (en) 2005-04-28

Family

ID=9950583

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/000294 WO2004060433A2 (en) 2003-01-02 2004-01-02 Delivery devices

Country Status (2)

Country Link
GB (2) GB0300008D0 (en)
WO (1) WO2004060433A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD759805S1 (en) 2013-05-23 2016-06-21 Optinose As Nosepiece unit
US9452272B2 (en) 2003-08-14 2016-09-27 Optinose As Delivery devices
US9522243B2 (en) 2002-07-02 2016-12-20 Optinose As Nasal devices
US9566402B2 (en) 2003-05-20 2017-02-14 Optinose As Delivery Device and Method

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320171D0 (en) 2003-08-28 2003-10-01 Optinose As Delivery devices
GB0420513D0 (en) 2004-09-15 2004-10-20 Optinose As Powder delivery devices
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
EP1984049A1 (en) 2006-01-19 2008-10-29 Optinose AS Nasal administration
GB0602980D0 (en) * 2006-02-14 2006-03-29 Optinose As Delivery device and method
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0604444D0 (en) 2006-03-06 2006-04-12 Optinose As Nasal devices
GB0605799D0 (en) 2006-03-23 2006-05-03 Optinose As Nasal delivery devices
GB2438834A (en) 2006-06-08 2007-12-12 Optinose As Intranasal protein administration
GB2440316A (en) 2006-07-25 2008-01-30 Optinose As Nasal inhaler with scrubber
GB0623731D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery device
GB0623732D0 (en) * 2006-11-28 2007-01-10 Optinose As Powder delivery devices
GB0623728D0 (en) 2006-11-28 2007-01-10 Optinose As Delivery devices
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
GB2448193A (en) 2007-04-05 2008-10-08 Optinose As Nasal delivery device
GB0719299D0 (en) 2007-10-03 2007-11-14 Optinose As Nasal delivery devices
GB201015371D0 (en) 2010-09-14 2010-10-27 Optinose As Nasal delivery
US9949923B2 (en) 2011-03-15 2018-04-24 Optinose As Nasal delivery
EP2817052B1 (en) 2012-02-24 2017-09-13 Optinose AS Nasal delivery devices
EP2817053B1 (en) 2012-02-24 2018-05-30 Optinose AS Nasal delivery devices
MX358061B (en) 2012-02-24 2018-08-03 Optinose As Nasal delivery devices.
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
AU2015348297A1 (en) 2014-11-19 2017-05-25 Optinose As Intranasal administration
US20160199599A1 (en) * 2015-01-13 2016-07-14 Bhl Patent Holdings Llc Nasal Delivery Device and Methods of Use
WO2019178693A1 (en) * 2018-03-21 2019-09-26 Protecsom Amerique Du Nord Inc. Nasal cannula for an aerosol reservoir such as an inhalation chamber
WO2020005910A1 (en) 2018-06-28 2020-01-02 Sandler Scientific, Llc Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system
CN110161198B (en) * 2019-05-28 2021-09-07 南京樟益医药科技有限公司 A analytical equipment for detecting nasal part is dosed

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782832A (en) * 1987-07-30 1988-11-08 Puritan-Bennett Corporation Nasal puff with adjustable sealing means
WO1992021404A1 (en) * 1991-05-31 1992-12-10 Bechgaard International Research And Development A/S Nasal dispenser actuated by nose contact
US5269296A (en) * 1991-10-29 1993-12-14 Landis Robert M Nasal continuous positive airway pressure apparatus and method
EP0779078A1 (en) * 1995-06-30 1997-06-18 Unisia Jecs Corporation Nasal cavity medicator and method of using same
US5906198A (en) * 1996-07-16 1999-05-25 Flickinger; William J. Nasal nebulizer
WO2000051672A1 (en) * 1999-03-03 2000-09-08 Optinose As Nasal delivery device
WO2002004056A1 (en) * 2000-07-06 2002-01-17 Bespak Plc Dispensing apparatus
WO2002068029A2 (en) * 2001-02-26 2002-09-06 Optinose As Nasal delivery devices
US6494204B1 (en) * 2000-06-23 2002-12-17 Pedro D. Ponce Nasal medication administering device
WO2003000310A2 (en) * 2001-06-12 2003-01-03 Optinose As Nasal devices
WO2004020029A1 (en) * 2002-08-27 2004-03-11 Pari GmbH Spezialisten für effektive Inhalation Therapeutic aerosol device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
WO1999008689A1 (en) * 1997-08-21 1999-02-25 Powderject Vaccines, Inc. Mucosal immunization using particle-mediated delivery techniques
ES2243229T3 (en) * 1999-02-03 2005-12-01 Powderject Res Ltd FORMULATIONS OF HYDROGEL PARTICLES.
US6601581B1 (en) * 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
GB0100756D0 (en) * 2001-01-11 2001-02-21 Powderject Res Ltd Needleless syringe

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782832A (en) * 1987-07-30 1988-11-08 Puritan-Bennett Corporation Nasal puff with adjustable sealing means
WO1992021404A1 (en) * 1991-05-31 1992-12-10 Bechgaard International Research And Development A/S Nasal dispenser actuated by nose contact
US5269296A (en) * 1991-10-29 1993-12-14 Landis Robert M Nasal continuous positive airway pressure apparatus and method
EP0779078A1 (en) * 1995-06-30 1997-06-18 Unisia Jecs Corporation Nasal cavity medicator and method of using same
US5906198A (en) * 1996-07-16 1999-05-25 Flickinger; William J. Nasal nebulizer
WO2000051672A1 (en) * 1999-03-03 2000-09-08 Optinose As Nasal delivery device
US6494204B1 (en) * 2000-06-23 2002-12-17 Pedro D. Ponce Nasal medication administering device
WO2002004056A1 (en) * 2000-07-06 2002-01-17 Bespak Plc Dispensing apparatus
WO2002068029A2 (en) * 2001-02-26 2002-09-06 Optinose As Nasal delivery devices
WO2003000310A2 (en) * 2001-06-12 2003-01-03 Optinose As Nasal devices
WO2004020029A1 (en) * 2002-08-27 2004-03-11 Pari GmbH Spezialisten für effektive Inhalation Therapeutic aerosol device
DE10239321B3 (en) * 2002-08-27 2004-04-08 Pari GmbH Spezialisten für effektive Inhalation Aerosol therapy device

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522243B2 (en) 2002-07-02 2016-12-20 Optinose As Nasal devices
US9566402B2 (en) 2003-05-20 2017-02-14 Optinose As Delivery Device and Method
US9452272B2 (en) 2003-08-14 2016-09-27 Optinose As Delivery devices
USD759805S1 (en) 2013-05-23 2016-06-21 Optinose As Nosepiece unit
USD761951S1 (en) 2013-05-23 2016-07-19 Optinose As Nosepiece unit
USD773644S1 (en) 2013-05-23 2016-12-06 Optinose As Nosepiece unit
USD809128S1 (en) 2013-05-23 2018-01-30 Optinose As Nosepiece unit

Also Published As

Publication number Publication date
GB2397025A (en) 2004-07-14
WO2004060433A2 (en) 2004-07-22
GB0400024D0 (en) 2004-02-04
GB0300008D0 (en) 2003-02-05
GB2397025B (en) 2007-09-05

Similar Documents

Publication Publication Date Title
WO2004060433A3 (en) Delivery devices
MXPA03011264A (en) Nasal devices.
WO2005016423A3 (en) Delivery devices
WO2003090812A3 (en) Nasal devices
WO2005021059A3 (en) Delivery devices
WO2004004814A3 (en) Nasal devices
GEP20063985B (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
WO2002094342A3 (en) Compositions for protein delivery via the pulmonary route
WO2001000263A3 (en) Systems and methods for aerosolizing pharmaceutical formulations
WO2002098390A3 (en) Delivery of aerosols containing small particles through an inhalation route
SE0102276L (en) Device and method for administering a substance
MXPA01010699A (en) Data processing system using a dual monitor and controlling method of network system thereby.
WO2006059152A3 (en) Pharmaceutical formulations
AU2003225071A1 (en) Aerosol medication delivery apparatus with narrow orifice
EP0855224A3 (en) Atomizer
GB2380410B (en) Apparatus for the nasal or oral delivery of a medicament
DE60041610D1 (en) Apparatus for dispensing metered quantities of medicament-containing aerosol
WO2003066131A3 (en) Agent delivery and aspiration device
WO2003059413A3 (en) Aerosol generator for drug formulation
CA2445516A1 (en) Metered dose delivery device for liquid and powder agents
AU2003217950A8 (en) Agglomerated particles for aerosol drug delivery
WO2003030995A3 (en) Apparatus comprising a pneumoacoustic atomizer
AU2003265869A8 (en) Interactive character for use with an aerosol medication delivery system
WO2004041326A3 (en) Tubular nozzles for use in systems for delivering medicaments
WO2002015876A3 (en) Amorphous carrier materials for drug delivery

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established
122 Ep: pct application non-entry in european phase